International Journal of Biomedicine. 2023;13(3):165-168.
Originally published September 5, 2023
Background: In this article, we highlight the importance of utilizing multiple imaging modalities, including CT, MRI, and abdominal Doppler ultrasound, to accurately differentiate between atypical liver hemangiomas (LH) and metastases.
Case report: We introduce a 57-year-old male patient who presented with severe abdominal pain. Initial CT scan findings showed hypodense liver lesions and a well-defined hypodense mass in the sub-diaphragmatic region, raising suspicion for metastatic liver lesions, and prompting further evaluation. To differentiate between atypical hemangiomas and metastases, an MRI scan was performed, revealing a hyperintense signal on T2-weighted images and a hypointense signal on T1-weighted images, consistent with the characteristics of LH. These characteristic signal intensities aided in ruling out metastatic liver lesions, which typically present with a more solid and homogeneous appearance. Contrast-enhanced MRI played a crucial role in confirming the diagnosis. The liver lesions demonstrated moderate vascularization during the early phase of contrast enhancement, followed by progressive centripetal filling during the portal venous and delayed phases. This enhancement pattern is consistent with the slow flow within the dilated vascular spaces of liver hemangiomas. The lesion in the right liver lobe is almost completely filled with contrast, further supporting the diagnosis of hemangioma. Abdominal Doppler ultrasound can provide additional information regarding the vascularity of liver lesions. In this case, the Doppler examination likely helped to further confirm the presence of a hemangioma, as these lesions typically demonstrate increased vascularity compared to metastatic lesions.
Conclusion: The comprehensive imaging evaluation utilizing CT, MRI, and abdominal Doppler ultrasound allowed for the confident differentiation of atypical liver hemangiomas from metastatic liver lesions in this case. This emphasizes the importance of a multimodal imaging approach in cases of liver lesions with overlapping features, leading to improved patient management and outcomes.
- Bajenaru N, Balaban V, Săvulescu F, Campeanu I, Patrascu T. Hepatic hemangioma -review-. J Med Life. 2015;8 Spec Issue(Spec Issue):4-11. PMID: 26361504; PMCID: PMC4564031.
- Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, Samir AE, Silva AC, Taouli B, Torbenson MS, Wells ML, Yeh B, Miller FH. Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY). 2017 Aug;42(8):2037-2053. doi: 10.1007/s00261-017-1211-7.
- Zhang W, Huang ZY, Ke CS, Wu C, Zhang ZW, Zhang BX, Chen YF, Zhang WG, Zhu P, Chen XP. Surgical Treatment of Giant Liver Hemangioma Larger Than 10 cm: A Single Center's Experience With 86 Patients. Medicine (Baltimore). 2015 Aug;94(34):e1420. doi: 10.1097/MD.0000000000001420.
- Werner JA, Dünne AA, Folz BJ, Rochels R, Bien S, Ramaswamy A, Lippert BM. Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol. 2001 Mar;258(3):141-9. doi: 10.1007/s004050100318.
- Tateyama A, Fukukura Y, Takumi K, Shindo T, Kumagae Y, Kamimura K, Nakajo M. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography. World J Gastroenterol. 2012 Nov 21;18(43):6269-76. doi: 10.3748/wjg.v18.i43.6269.
- Zheng JG, Yao ZM, Shu CY, Zhang Y, Zhang X. Role of SPECT/CT in diagnosis of hepatic hemangiomas. World J Gastroenterol. 2005 Sep 14;11(34):5336-41. doi: 10.3748/wjg.v11.i34.5336.
- Lombardo DM, Baker ME, Spritzer CE, Blinder R, Meyers W, Herfkens RJ. Hepatic hemangiomas vs metastases: MR differentiation at 1.5 T. AJR Am J Roentgenol. 1990 Jul;155(1):55-9. doi: 10.2214/ajr.155.1.2112864.
- Takayama Y, Nishie A, Okamoto D, Fujita N, Asayama Y, Ushijima Y, Yoshizumi T, Yoneyama M, Ishigami K. Differentiating Liver Hemangioma from Metastatic Tumor Using T2-enhanced Spin-echo Imaging with a Time-reversed Gradient-echo Sequence in the Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging. Magn Reson Med Sci. 2022 Jul 1;21(3):445-457. doi: 10.2463/mrms.mp.2020-0151.
- Nouira K, Allani R, Bougamra I, Bouzaidi K, Azaiez O, Mizouni H, Messaoud MB, Menif E. Atypical small hemangiomas of the liver: hypervascular hemangiomas. Int J Biomed Sci. 2007 Dec;3(4):302-4. PMID: 23675058; PMCID: PMC3614658.
- Sivrioglu AK, Kafadar C. Differentiation between hepatic hemangioma and metastases on diffusion-weighted MRI. Clin Imaging. 2016 Jan-Feb;40(1):183. doi: 10.1016/j.clinimag.2015.09.018.
- Hui C, Sum R. Hepatic GIST metastases: an illustrative case series. BJR Case Rep. 2022 Jan 10;8(2):20210166. doi: 10.1259/bjrcr.20210166.
- Coenegrachts K. Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions. World J Radiol. 2009 Dec 31;1(1):72-85. doi: 10.4329/wjr.v1.i1.72.
- Matos AP, Velloni F, Ramalho M, AlObaidy M, Rajapaksha A, Semelka RC. Focal liver lesions: Practical magnetic resonance imaging approach. World J Hepatol. 2015 Aug 8;7(16):1987-2008. doi: 10.4254/wjh.v7.i16.1987.
- Mamone G, Di Piazza A, Carollo V, Cannataci C, Cortis K, Bartolotta TV, Miraglia R. Imaging of hepatic hemangioma: from A to Z. Abdom Radiol (NY). 2020 Mar;45(3):672-691. doi: 10.1007/s00261-019-02294-8.
Received June 1, 2023.
Accepted July 5, 2023.
©2023 International Medical Research and Development Corporation.